Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study.

Cancer Immunol Immunother · 2020 · PMC7413875 · PMID 32333081

Europe PMC DOI

hedged sentence

0.0546

closest p · 1.1× alpha

0.0546

boldest claim

The sentences

marginally significantP = 0.0546so close (0.05 < p ≤ 0.1)

A significant increase in CD3-CD16 + CD56 + cells (natural killer cells; P = 0.0124) and a marginally significant decrease in CD4 + CD25 + cells (regulatory T cells; P = 0.0546) were observed three weeks after the first cycle of treatment in the combined stage.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.